Press Releases Crescita Therapeutics Inc.

Equities

Market Closed - Toronto S.E. Other stock markets 12:32:13 11/05/2024 am IST			5-day change	1st Jan Change
0.435 ^CAD	0.00%		+1.16%	-11.22%

08/05	Crescita Therapeutics Q1 Loss Widens, Revenue Rises	MT
08/05	Crescita Therapeutics Brief: Q1 Revenue was $4.996 Million	MT

Crescita Reports First Quarter 2024 Results	08/05	BU
Crescita Reports Q4 and Fiscal 2023 Results	13/03	BU
Crescita Reports Third Quarter 2023 Results	08/11	BU
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid	29/23/29	BU
Crescita Reports Second Quarter 2023 Results	09/23/09	BU
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders	21/23/21	BU
Crescita Reports First Quarter 2023 Results	11/23/11	BU
Crescita Reports Q4 and Fiscal 2022 Results	15/23/15	BU
Crescita Reports Third Quarter 2022 Results	09/22/09	BU
Crescita Reports Second Quarter 2022 Results	10/22/10	BU
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders	13/22/13	BU
Crescita Reports First Quarter 2022 Results	11/22/11	BU
Crescita to Present at Bloom Burton & Co. Healthcare Investor Conference	22/22/22	BU
Crescita Reports Q4 and Fiscal 2021 Results	23/22/23	BU
Crescita Therapeutics Announces Renewal of Normal Course Issuer Bid	15/21/15	BU
Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis	14/21/14	AQ
Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®	13/21/13	BU
Crescita Reports Third Quarter 2021 Results and Appoints New Board Member	11/21/11	BU
Crescita Therapeutics : Announces Exclusive Canadian Distribution Agreement with Obagi Cosmeceuticals LLC	09/21/09	BU
Crescita Therapeutics : Acquires Minority Interest in The Best You®	07/21/07	BU

No results for this search